Qiagen Statistics
Total Valuation
Qiagen has a market cap or net worth of $9.63 billion. The enterprise value is $10.10 billion.
| Market Cap | 9.63B |
| Enterprise Value | 10.10B |
Important Dates
The last earnings date was Tuesday, November 4, 2025, after market close.
| Earnings Date | Nov 4, 2025 |
| Ex-Dividend Date | Jul 2, 2025 |
Share Statistics
Qiagen has 216.84 million shares outstanding. The number of shares has increased by 1.61% in one year.
| Current Share Class | 216.84M |
| Shares Outstanding | 216.84M |
| Shares Change (YoY) | +1.61% |
| Shares Change (QoQ) | +0.12% |
| Owned by Insiders (%) | 0.45% |
| Owned by Institutions (%) | 85.73% |
| Float | 214.79M |
Valuation Ratios
The trailing PE ratio is 24.16 and the forward PE ratio is 18.04. Qiagen's PEG ratio is 2.17.
| PE Ratio | 24.16 |
| Forward PE | 18.04 |
| PS Ratio | 4.66 |
| Forward PS | 4.37 |
| PB Ratio | 2.64 |
| P/TBV Ratio | 12.08 |
| P/FCF Ratio | 20.12 |
| P/OCF Ratio | 14.65 |
| PEG Ratio | 2.17 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 9.93, with an EV/FCF ratio of 21.09.
| EV / Earnings | 24.92 |
| EV / Sales | 4.88 |
| EV / EBITDA | 9.93 |
| EV / EBIT | 12.02 |
| EV / FCF | 21.09 |
Financial Position
The company has a current ratio of 2.60, with a Debt / Equity ratio of 0.59.
| Current Ratio | 2.60 |
| Quick Ratio | 2.14 |
| Debt / Equity | 0.59 |
| Debt / EBITDA | 2.06 |
| Debt / FCF | 4.50 |
| Interest Coverage | 24.53 |
Financial Efficiency
Return on equity (ROE) is 11.29% and return on invested capital (ROIC) is 9.26%.
| Return on Equity (ROE) | 11.29% |
| Return on Assets (ROA) | 8.19% |
| Return on Invested Capital (ROIC) | 9.26% |
| Return on Capital Employed (ROCE) | 15.06% |
| Revenue Per Employee | $347,039 |
| Profits Per Employee | $67,936 |
| Employee Count | 5,967 |
| Asset Turnover | 0.32 |
| Inventory Turnover | 1.34 |
Taxes
In the past 12 months, Qiagen has paid $101.58 million in taxes.
| Income Tax | 101.58M |
| Effective Tax Rate | 20.04% |
Stock Price Statistics
The stock price has increased by +5.38% in the last 52 weeks. The beta is 0.68, so Qiagen's price volatility has been lower than the market average.
| Beta (5Y) | 0.68 |
| 52-Week Price Change | +5.38% |
| 50-Day Moving Average | 46.02 |
| 200-Day Moving Average | 44.68 |
| Relative Strength Index (RSI) | 41.67 |
| Average Volume (20 Days) | 1,326,365 |
Short Selling Information
| Short Interest | 6.10M |
| Short Previous Month | 6.68M |
| Short % of Shares Out | 2.81% |
| Short % of Float | 2.84% |
| Short Ratio (days to cover) | 6.27 |
Income Statement
In the last 12 months, Qiagen had revenue of $2.07 billion and earned $405.37 million in profits. Earnings per share was $1.84.
| Revenue | 2.07B |
| Gross Profit | 1.66B |
| Operating Income | 840.56M |
| Pretax Income | 506.95M |
| Net Income | 405.37M |
| EBITDA | 1.02B |
| EBIT | 840.56M |
| Earnings Per Share (EPS) | $1.84 |
Balance Sheet
The company has $1.69 billion in cash and $2.16 billion in debt, giving a net cash position of -$466.30 million or -$2.15 per share.
| Cash & Cash Equivalents | 1.69B |
| Total Debt | 2.16B |
| Net Cash | -466.30M |
| Net Cash Per Share | -$2.15 |
| Equity (Book Value) | 3.65B |
| Book Value Per Share | 16.83 |
| Working Capital | 1.56B |
Cash Flow
In the last 12 months, operating cash flow was $657.70 million and capital expenditures -$178.83 million, giving a free cash flow of $478.88 million.
| Operating Cash Flow | 657.70M |
| Capital Expenditures | -178.83M |
| Free Cash Flow | 478.88M |
| FCF Per Share | $2.21 |
Margins
Gross margin is 80.27%, with operating and profit margins of 40.59% and 19.58%.
| Gross Margin | 80.27% |
| Operating Margin | 40.59% |
| Pretax Margin | 24.48% |
| Profit Margin | 19.58% |
| EBITDA Margin | 49.13% |
| EBIT Margin | 40.59% |
| FCF Margin | 23.13% |
Dividends & Yields
This stock pays an annual dividend of $1.51, which amounts to a dividend yield of 3.40%.
| Dividend Per Share | $1.51 |
| Dividend Yield | 3.40% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | 2 |
| Payout Ratio | 82.12% |
| Buyback Yield | -1.61% |
| Shareholder Yield | 1.79% |
| Earnings Yield | 4.21% |
| FCF Yield | 4.97% |
Analyst Forecast
The average price target for Qiagen is $50.68, which is 14.07% higher than the current price. The consensus rating is "Buy".
| Price Target | $50.68 |
| Price Target Difference | 14.07% |
| Analyst Consensus | Buy |
| Analyst Count | 7 |
| Revenue Growth Forecast (5Y) | 8.32% |
| EPS Growth Forecast (5Y) | 54.84% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on January 29, 2025. It was a reverse split with a ratio of 1:1.03.
| Last Split Date | Jan 29, 2025 |
| Split Type | Reverse |
| Split Ratio | 1:1.03 |
Scores
Qiagen has an Altman Z-Score of 3.58 and a Piotroski F-Score of 6.
| Altman Z-Score | 3.58 |
| Piotroski F-Score | 6 |